Mapping the Landscape of COVID-19 Clinical Trials in the US
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread. As several entities [...]
Elements of Pharmaceutical/Biotech Pricing Short Course
ISPOR announced that it will hold a 4-hour short course entitled ‘Elements of Pharmaceutical/Biotech Pricing Short Course’ on December 9, [...]
Virtual ISPOR 2021 Abstract Submission Deadline Extended
Given the constraints of the current environment, ISPOR has extended the deadline for issue panel and workshop proposals to December [...]
Cytel Acquires Purple Squirrel Economics
Cytel Inc., a leading provider of advanced analytics for the life sciences industry, has announced the acquisition of Purple Squirrel [...]
ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports
The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize [...]
[Webinar] How Payers, the Life Science Industry, and Others Can Move from Insight to Action
On December 17, 2020, from 10:00 to 11:00 a.m. EST, ICER will host a webinar to demo ICER Analytics™, a [...]
Informed Consent in the Context of COVID-19
Clinical research is world widely speeding in order to identify as soon as possible COVID-19 treatment and vaccine. Clinical trials [...]
ICER Releases Report on Therapies for Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) today released a Draft Evidence Report assessing the comparative clinical effectiveness and value of [...]
Upcoming ISPOR Webinar Opportunities
ISPOR is offering a number of upcoming webinars that are now available for registration. These webinars are complimentary for both [...]
[Webinar] Use of Real World Evidence in Clinical Development to Enhance Regulatory Submission
More pharmaceutical companies are working to understand how real world evidence (RWE) can strengthen their submission packages and identifying opportunities [...]
How Real World Evidence from Patient Support Programs Can Enhance Patient Care
This IQVIA blog post details how Patient Support Programs (PSP) have evolved from providing drug bridging and financial support to [...]
The NICE methods of health technology evaluation: the case for change
NICE recently posted a consultation entitled "The NICE methods of health technology evaluation: the case for change" which details its [...]
Vibra Healthcare and Ernest Health Select Inovalon’s EASE® All-Payer Solution
Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, today announced separate 5-year agreements with two prominent post-acute care [...]
ICER Publishes Final Report on Hemophilia A Therapies
Today the Institute for Clinical and Economic Review (ICER) released a report concluding that compared to common current dosing levels [...]
Conduent Joins with Experian Health to Expand Patient Assistance Capabilities
Conduent recently announced a commercial agreement with Experian Health, a leading provider of revenue cycle management products that include patient engagement, patient access and patient collections. The [...]
Health Equity Should Be Key to Value-Based Payment And Delivery Reform
The COVID-19 pandemic has exposed and exacerbated existing health inequities in the United States. Black and Latinx Americans have experienced [...]
Balancing Lower U.S. Prescription Drug Prices And Innovation
This Health Affairs blog post provides background on U.S. drug prices and summarizes an expert roundtable discussion held in June [...]
Amazon Opens Online Pharmacy
The retail colossus opened an online pharmacy Tuesday that allows customers to order medication or prescription refills, and have them [...]
Call for Proposals: Health Data for Action
The Robert Wood Johnson Foundation’s (RWJF) signature research program, Health Data for Action: Leveraging Health Data for Actionable Insights (HD4A), aims to [...]
Value-Based Pricing For Treatments And Vaccines In The Context of COVID-19
Referencing ICER’s white paper and webinar series on the same topic, researchers at Tufts' Center for the Evaluation of Value and [...]
AMCP Foundation is Now Accepting 2021 Summer Internship Applications
AMCP Foundation is now seeking applicants for the following programs: AMCP Foundation/AbbVie, Inc. Specialized Summer Internship Program in Health Outcomes [...]
The Problem With Discriminatory Value Assessments
By utilizing discriminatory value assessments, foreign governments like in the U.K., have created barriers to care for individuals w/ disabilities [...]
Virtual ISPOR Short Course on Reimbursement Systems for Pharmaceuticals in Europe
On December 1-2, 2020, this course will discuss health technology decision-making processes for reimbursement decisions for pharmaceuticals in France, Germany, [...]
[Webinar] European Pharma Trends Beyond the Pandemic
Tune in on November 24th at 8 am EST /1pm GMT for the third and final webinar of the series: [...]
What Now for Remdesivir?
The World Health Organization advised against using remdesivir to treat patients hospitalized with COVID-19, citing a recent WHO-sponsored study that [...]